Skip to main content
Signal8
Sperzel John J III profile photo

John J. Sperzel III

CIK: 0001602618

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

T2 Biosystems, Inc. logo
TTOO

T2 Biosystems, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • T2 Biosystems, Inc. logo
    TTOO

    T2 Biosystems, Inc.

    Nov 4, 2024
    Award(A)

    Restricted Stock Units

    Direct
    490K shares-
  • T2 Biosystems, Inc. logo
    TTOO

    T2 Biosystems, Inc.

    Nov 4, 2024
    Award(A)

    Restricted Stock Units

    Direct
    490K shares-

1-2 of 2

John J. Sperzel III files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO). Signal8 holds 2 reported Form 4/5 transactions by John J. Sperzel III since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.

About Sperzel John J III

Sperzel John J III (SEC CIK 0001602618) files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO).

Signal8 holds 1 ownership filing by Sperzel John J III, a Form 4, filed on Jan 2, 2025. Those filings report 2 transactions, the latest on Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Sperzel John J III's filings is in LEXINGTON, MA.

Recent filings by Sperzel John J III

  • Nov 4, 2024: Grants or awards of TTOO derivative securities (2 lines, Form 4, code A).

Other insiders filing for T2 Biosystems, Inc. (TTOO)

How to read Form 4 transaction codes